These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 9127380)
21. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma. Cao J; Zhang ZY; Patima ; Zhang YX; Chen WT Chin J Dent Res; 2000 Nov; 3(3):44-9. PubMed ID: 11314535 [TBL] [Abstract][Full Text] [Related]
22. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. Mitra S; Banerjee S; Misra C; Singh RK; Roy A; Sengupta A; Panda CK; Roychoudhury S J Clin Pathol; 2007 Sep; 60(9):1040-7. PubMed ID: 17079356 [TBL] [Abstract][Full Text] [Related]
23. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Nemes JA; Deli L; Nemes Z; Márton IJ Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543 [TBL] [Abstract][Full Text] [Related]
24. Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development. Llorens C; Soriano B; Trilla-Fuertes L; Bagan L; Ramos-Ruiz R; Gamez-Pozo A; Peña C; Bagan JV Clin Oral Investig; 2021 May; 25(5):2645-2657. PubMed ID: 32918120 [TBL] [Abstract][Full Text] [Related]
25. Low prevalence of high risk genotypes of human papilloma virus in normal oral mucosa, oral leukoplakia and verrucous carcinoma. Saghravanian N; Ghazvini K; Babakoohi S; Firooz A; Mohtasham N Acta Odontol Scand; 2011 Nov; 69(6):406-9. PubMed ID: 21466259 [TBL] [Abstract][Full Text] [Related]
26. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection. Bagan JV; Jimenez Y; Murillo J; Gavaldá C; Poveda R; Scully C; Alberola TM; Torres-Puente M; Pérez-Alonso M J Oral Maxillofac Surg; 2007 Jan; 65(1):46-9. PubMed ID: 17174763 [TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation. Yang SW; Lee YS; Chen TA; Wu CJ; Tsai CN Cancer Epidemiol; 2009 Aug; 33(2):118-22. PubMed ID: 19679058 [TBL] [Abstract][Full Text] [Related]
28. Retrospective case-control study of viral pathogen screening in proliferative verrucous leukoplakia lesions. García-López R; Moya A; Bagan JV; Pérez-Brocal V Clin Otolaryngol; 2014 Oct; 39(5):272-80. PubMed ID: 25099922 [TBL] [Abstract][Full Text] [Related]
29. A Retrospective 20-Year Analysis of Proliferative Verrucous Leukoplakia and Its Progression to Malignancy and Association with High-risk Human Papillomavirus. Upadhyaya JD; Fitzpatrick SG; Islam MN; Bhattacharyya I; Cohen DM Head Neck Pathol; 2018 Dec; 12(4):500-510. PubMed ID: 29427033 [TBL] [Abstract][Full Text] [Related]
30. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Girod SC; Pfeiffer P; Ries J; Pape HD Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus in the proliferative diseases of squamous epithelium in the oral cavity. Horiuchi K; Mishima K; Ichijima K; Sugimura M; Ishida T; Kirita T Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jan; 79(1):57-63. PubMed ID: 7614163 [TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: A preliminary study. Bagan JV; Jiménez Y; Murillo J; Poveda R; Díaz JM; Gavaldá C; Margaix M; Scully C; Alberola TM; Torres Puente M; Pérez Alonso M Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E110-3. PubMed ID: 18223526 [TBL] [Abstract][Full Text] [Related]
33. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Silverman S; Gorsky M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Aug; 84(2):154-7. PubMed ID: 9269017 [TBL] [Abstract][Full Text] [Related]
34. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival. Kozomara R; Jović N; Magić Z; Branković-Magić M; Minić V J Craniomaxillofac Surg; 2005 Oct; 33(5):342-8. PubMed ID: 16129609 [TBL] [Abstract][Full Text] [Related]
35. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia. Wood MW; Medina JE; Thompson GC; Houck JR; Min KW Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509 [TBL] [Abstract][Full Text] [Related]
36. Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL. Femiano F; Gombos F; Scully C Int J Oral Maxillofac Surg; 2001 Aug; 30(4):318-22. PubMed ID: 11518355 [TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia]. Kikegawa A Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806 [TBL] [Abstract][Full Text] [Related]
38. [Analysis of expression of p53 tumor suppressor gene in human oral squamous cell carcinoma]. Okuno-Ishii N Kokubyo Gakkai Zasshi; 1993 Mar; 60(1):131-48. PubMed ID: 8482898 [TBL] [Abstract][Full Text] [Related]
39. Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples. Majumder M; Indra D; Roy PD; Datta S; Ray JG; Panda CK; Roy B J Oral Pathol Med; 2009 Feb; 38(2):174-80. PubMed ID: 18764855 [TBL] [Abstract][Full Text] [Related]
40. p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract. Lee NK; Ye YW; Chen J; Li X; Waber PG; Nisen PD Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1125-31. PubMed ID: 8398064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]